Establishment Labs Holdings Inc. (NASDAQ:ESTA) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) have been assigned an average rating of “Moderate Buy” from the eight research firms that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $87.00.

Several equities analysts have recently issued reports on ESTA shares. Citigroup boosted their target price on Establishment Labs from $62.00 to $75.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Weiss Ratings restated a “sell (e+)” rating on shares of Establishment Labs in a research note on Monday, December 29th. Needham & Company LLC lifted their target price on shares of Establishment Labs from $84.00 to $86.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. BTIG Research upped their price target on Establishment Labs from $86.00 to $88.00 and gave the company a “buy” rating in a report on Tuesday, February 24th. Finally, Stephens lifted their price objective on Establishment Labs from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Wednesday, February 25th.

Institutional Trading of Establishment Labs

Several institutional investors and hedge funds have recently modified their holdings of the company. MV Capital Management Inc. bought a new stake in Establishment Labs during the 4th quarter valued at approximately $146,000. ADAR1 Capital Management LLC grew its position in Establishment Labs by 89.0% in the fourth quarter. ADAR1 Capital Management LLC now owns 171,422 shares of the company’s stock worth $12,493,000 after acquiring an additional 80,734 shares in the last quarter. Voloridge Investment Management LLC bought a new stake in Establishment Labs during the fourth quarter worth approximately $3,421,000. SummitTX Capital L.P. bought a new stake in shares of Establishment Labs in the 4th quarter valued at approximately $2,519,000. Finally, Tudor Investment Corp ET AL purchased a new position in shares of Establishment Labs in the 4th quarter worth approximately $12,852,000. 72.91% of the stock is currently owned by institutional investors.

Establishment Labs Stock Performance

Shares of ESTA stock opened at $71.14 on Thursday. The company has a market capitalization of $2.09 billion, a P/E ratio of -40.88 and a beta of 0.91. Establishment Labs has a fifty-two week low of $26.56 and a fifty-two week high of $83.31. The company has a debt-to-equity ratio of 10.51, a quick ratio of 2.10 and a current ratio of 3.04. The stock has a 50 day moving average price of $71.10 and a two-hundred day moving average price of $59.22.

Establishment Labs (NASDAQ:ESTA) last issued its earnings results on Tuesday, February 24th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.22) by $0.13. The company had revenue of $64.62 million for the quarter, compared to the consensus estimate of $63.80 million. Establishment Labs had a negative net margin of 24.19% and a negative return on equity of 201.79%. The firm’s revenue for the quarter was up 45.2% on a year-over-year basis. During the same period in the previous year, the firm earned ($1.19) earnings per share. Analysts expect that Establishment Labs will post -2.41 earnings per share for the current year.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.